Harry Wilcox - BG Medicine Director
| BGMDDelisted Stock | USD 0.0002 0.00 0.00% |
Director
Mr. Harry W. Wilcox III is Chairman of the Board of BG Medicine, Inc. Mr. Wilcox was Chief Operating Officer and General Partner of Flagship Ventures, a VC firm, since 2013. From 2006 to 2013, he was Chief Financial Officer and Partner of Flagship Ventures. From 2004 to 2006, he was Chief Financial Officer and Senior Vice President of Corporationrationrate Development of EXACT Sciences. Mr. Wilcox received his M.B.A. from Boston University and his B.S. in Finance from the University of Arizona since 2015.
| Age | 62 |
| Tenure | 9 years |
| Phone | 781 890 1199 |
| Web | https://www.bg-medicine.com |
BG Medicine Management Efficiency
The company has return on total asset (ROA) of (0.7595) % which means that it has lost $0.7595 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (9.0264) %, meaning that it created substantial loss on money invested by shareholders. BG Medicine's management efficiency ratios could be used to measure how well BG Medicine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | DIRECTOR Age | ||
| Frank DiPasquale | Innovative Eyewear | 52 | |
| Solomon Mayer | Microbot Medical | 62 | |
| Martin Madden | Microbot Medical | 57 | |
| Moshe Shoham | Microbot Medical | 64 | |
| Scott Burell | Microbot Medical | 52 | |
| Yoav Waizer | Microbot Medical | 51 | |
| Ralph Singer | Innovative Eyewear | 59 | |
| George Bell | Innovative Eyewear | 57 | |
| Prattipati Laxminarain | Microbot Medical | 59 | |
| Yoseph Bornstein | Microbot Medical | 65 | |
Management Performance
| Return On Equity | -9.03 | ||||
| Return On Asset | -0.76 |
BG Medicine Leadership Team
Elected by the shareholders, the BG Medicine's board of directors comprises two types of representatives: BG Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BGMD. The board's role is to monitor BG Medicine's management team and ensure that shareholders' interests are well served. BG Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BG Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Connor, Director | ||
| Harry Wilcox, Director | ||
| Stelios Papadopoulos, Independent Director | ||
| Aram Adourian, Chief Scientific Officer and Sr. VP | ||
| Stephen Hall, CFO, Principal Accounting Officer, Executive VP and Treasurer | ||
| Jeffrey Luber, Director | ||
| Paul Sohmer, President CEO, Director | ||
| Noubar Afeyan, Founder | ||
| James OConnor, Independent Director |
BGMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is BG Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -9.03 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (2.86) % | ||||
| Current Valuation | 545.97 K | ||||
| Shares Outstanding | 11.37 M | ||||
| Number Of Shares Shorted | 630.05 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 1.06 M |
Pair Trading with BG Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BG Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BG Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against BGMD Pink Sheet
| 0.58 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.53 | DOMH | Dominari Holdings | PairCorr |
| 0.47 | YS | YS Biopharma | PairCorr |
The ability to find closely correlated positions to BG Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BG Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BG Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BG Medicine to buy it.
The correlation of BG Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BG Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BG Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BG Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in BGMD Pink Sheet
If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |